Patents Assigned to UNIVERSITE DE GENEVA
  • BARD1 isoforms in lung and colorectal cancer and use thereof
    Patent number: 11022612
    Abstract: The present invention relates to new BARD1 isoforms specific to lung cancer and colorectal cancer, a method for detecting thereof and a method for treating and/or preventing lung cancer and colorectal cancer.
    Type: Grant
    Filed: January 27, 2017
    Date of Patent: June 1, 2021
    Assignees: HOPITAUX UNIVERSITAIRES DE GENEVE, UNIVERSITE DE GENEVA
    Inventors: Irmgard Irminger-Finger, Yong-Qiang Zhang